Fizyhealth
Scripts company profile

Scripts company profile: what is public, what is not

Scripts is a Group Purchasing Organization (GPO) and multi-pharmacy fulfillment intermediary at scripts.co, headquartered at 4730 S Fort Apache Rd, Ste 300, Las Vegas, NV 89147. Co-founder Jeff Sakamoto has been publicly interviewed about the company's origin and model. Beyond the product, co-founders, and headquarters, Scripts does not publish funding history or customer counts on its public site as of June 2026.

If you are doing vendor due diligence on Scripts as a company, this page separates the publicly verifiable facts from the details Scripts does not disclose — without filling the gaps with guesses.

Compare Fizy Health vs Scripts

Proudly Partnered With

What is publicly verifiable about Scripts?

What can be verified from Scripts's public materials includes the product model and key company facts. Scripts is a business-to-business GPO and fulfillment intermediary, reachable at scripts.co, headquartered at 4730 S Fort Apache Rd, Ste 300, Las Vegas, NV 89147, with a contact of [email protected]. Co-founder Jeff Sakamoto has been publicly interviewed on the HRT University podcast (ep. 67, December 2025) — his background is private equity and institutional real estate, with a personal TRT experience that led him to co-found the platform. Scripts serves clinics, med spas, and telehealth brands across all 50 states with compounded GLP-1s, hormones, peptides, hair restoration, sexual health, and longevity therapies via a vetted 503A and 503B pharmacy network. What is not on the public site as of June 2026 is financial detail: funding history, investor names, and customer or order counts are not disclosed.

Who needs this profile

Due diligence falls to the people signing the contract.

A company profile matters most to the roles responsible for vendor risk before a clinic commits. Three of them carry that weight.

  • Owners

    Founders accepting vendor risk.

    Owners sign the agreement, so they carry the risk of a vendor whose financial details are not publicly disclosed. Their question is what can be confirmed about company stability and standing — and what to request directly when the website is silent. Co-founder Jeff Sakamoto's public interview provides more context than many B2B vendor sites offer.

  • Operators

    Ops leads assessing reliability.

    Operations staff depend on the platform daily, so company longevity and support responsiveness matter to them. With funding and customer counts undisclosed, they evaluate reliability through references, the concierge team's performance, and the contract terms rather than published metrics.

  • Prescribers

    Providers confirming legitimacy.

    Prescribers want assurance the platform routes to legitimate, licensed 503A and 503B pharmacies. Scripts states that it personally visits and monitors partner pharmacies. Their due diligence centers on verifying the certification and state licensure of the specific pharmacies behind each order.

What is publicly known about Scripts

Scripts's public materials confirm the following: the company is a GPO and multi-pharmacy fulfillment intermediary headquartered in Las Vegas, NV. Co-founder Jeff Sakamoto described the company's origin in a December 2025 HRT University podcast interview — his path from private equity to men's health led him to build Scripts as a response to the fragmented, multi-portal pharmacy logistics that telehealth clinics struggled with. The platform has been cited by clinics in testimonials on the scripts.co homepage, though Scripts does not publish a verified customer count or aggregate order volume.

Scripts also discloses its pharmacy partner model publicly: it claims to personally visit and audit partner pharmacies, monitor ongoing performance, and remove pharmacies that cut corners. Many but not all partner pharmacies are LegitScript certified. The company offers certificates of analysis on request for its compounded products. These are the facts you can take into a buying conversation.

What to ask Scripts directly

Because financial and customer-volume details are not public, request them in the sales conversation: ask which legal entity you are contracting with, the specific 503A and 503B partner pharmacies your clinic would route to, and proof of their LegitScript certification and state licensure for the states your patients live in. Ask for references from clinics comparable in size and specialty to yours, and review the contract and cancellation terms before signing.

For a transparent point of comparison, Fizy Health publishes its model openly: pass-through per-vial 503A pricing shown before checkout, a disclosed facilitation fee, LegitScript-certified partners, and a BAA at onboarding. That level of pre-commitment visibility is the standard to use when evaluating any vendor whose financial details are not public.

After due diligence — which platform fits your clinic?

Scripts fits if

Scripts

You want a vetted GPO with a co-founder-backed concierge model.

  • You are satisfied with what Scripts confirms about its company, partners, and 503A and 503B pharmacy network.
  • You need 503B office-use bulk access today and want a concierge team handling fulfillment coordination.
  • A vetting-call onboarding process works for your timeline and you value GPO-negotiated exclusive pricing.
Consider Fizy Health if

Fizy Health

You want pass-through pricing before the consult — and validation before you pay.

  • You want a vendor that publishes its pricing model and LegitScript-certified partner approach openly before you sign up.
  • You want SIG and licensure issues caught before payment — not after the pharmacy rejects the order.
  • You batch refills across multiple 503A partners and want one patient-linked cart, one validation pass, one checkout.
If you choose Fizy Health

What your clinic gets from a transparent pass-through platform.

Scripts and Fizy Health both consolidate 503A ordering. These are the outcomes that show up when pricing and the partner model are visible before you commit.

See all features
Keep evaluating Scripts

More answers in the Scripts evaluation guide.

See the full Scripts guide
FAQ

Company questions clinics ask about Scripts.

  • Company

    What is Scripts as a company?

    Scripts is a Group Purchasing Organization (GPO) and multi-pharmacy fulfillment intermediary headquartered at 4730 S Fort Apache Rd, Ste 300, Las Vegas, NV 89147. Its product and model are publicly verifiable; financial details like funding and customer counts are not disclosed on the public site as of June 2026.

  • Founder

    Who founded Scripts?

    Co-founder Jeff Sakamoto has been publicly interviewed about Scripts's origin. His background is in private equity and institutional real estate; a personal TRT experience led him to build Scripts as a response to the fragmented pharmacy portal problem in telehealth and cash-pay clinics.

  • Headquarters

    Where is Scripts headquartered?

    Scripts is headquartered at 4730 S Fort Apache Rd, Ste 300, Las Vegas, NV 89147, as listed on scripts.co. Contact the company at [email protected].

  • Funding

    Has Scripts raised funding?

    Scripts does not disclose funding history on its public site as of June 2026. There is no verifiable public record to cite here, so this profile reports it as undisclosed rather than guessing at investors or amounts.

  • Diligence

    What should I verify before signing with Scripts?

    Confirm the contracting legal entity, the specific 503A and 503B partner pharmacies and their LegitScript certification and state licensure for your patient states, references from comparable clinics, and the contract and cancellation terms. Ask for certificates of analysis on key SKUs.

  • Alternative

    How transparent is Fizy Health by comparison?

    Fizy Health publishes its model openly: pass-through per-vial 503A pricing shown in catalog before checkout, a disclosed facilitation fee, LegitScript-certified partners, and a BAA at onboarding — the kind of pre-commitment visibility to look for when a vendor's financial details are not public.

Sources reviewed June 2026

  • Scripts public website (scripts.co), reviewed June 2026. Funding, investor names, and customer counts are not disclosed on the public site as of this date.
  • HRT University podcast ep. 67 — Scripts co-founder Jeff Sakamoto interview (hrtuniversity.com/pod-ep-67), reviewed June 2026.
  • Fizy Health platform capabilities reflect the live product.
Evaluate with real numbers

Choose a platform that shows its model up front.

See how Fizy Health shows landed cost before you quote, validates orders before you pay, and keeps support in the app. Free to start.

Fizy Health vs ScriptsStart Ordering Free